Pharmaceutical Materials Division - Research & Development

Research and development in the Pharmaceutical Materials Division is directed towards the development of manufacturing processes for active pharmaceutical ingredients (APIs) to be manufactured and marketed by the division’s business units. Across the division the development of safe and cost effective manufacturing processes and the instrumental and chemical methods for detailed analysis of these products are fundamental technologies for the manufacture of commercial scale products. These technologies are essential to achieve competitive market positions and to obtain regulatory approval for products.

Each of the division’s businesses has developed substantial chemical know-how in their respective market niches and they collaborate closely on new technical challenges. Combined with Johnson Matthey’s core expertise in catalysis, chiral catalysis and organometallic chemistry, the division offers the pharmaceutical marketplace a unique range of R&D capabilities.

Back to Innovation